NASDAQ (USD): JIADE LIMITED Common stock (JDZG)
Last Price
2.09
Today's Change
+0.39 (22.94%)
Day's Change
1.80 - 2.66
Trading Volume
53,473,569
You are setting up a price and signal alert with 15 minutes delay. Click here to enjoy real-time price and signal alerts.
T4Q
31-Mar-2021
2020
2019
2018
2017
Stock Price
238
1000
110
900
600
12
MQ Chat
Send individual or group chats with anyone on i3investor
MQ Trader
Earn MQ Points while trading with MQ Trader
MQ Affiliate
Earn side income from Affiliate Program
MQdemy
Online learning and teaching marketplace
1
CEO Morning Brief
Cheaper Energy Products Depress US Import Prices in September
2
Cathay Asks Boeing to Remain Transparent About Aircraft Delays
3
Trump Defends Tariff Plan While Pressing for More Fed Influence
4
Fed’s Bostic Says US Employment and Growth to Stay Robust
5
Global Banks, Funds Including PNB, EPF Keep Ploughing Billions Into Clients Threatening Rainforests — Study
#
Stock
Score
AGN
TDS
Telephone and Data Systems, Inc.
800
NVDA
NVIDIA Corporation
DDOG
Datadog, Inc.
400
PIKE
6
IRM
Iron Mountain Incorporated
7
TYL
Tyler Technologies, Inc.
8
VZ
Verizon Communications Inc.
9
CAT
Caterpillar Inc.
10
GMLP
Last
Change
Volume
JTAI
0.103
+0.006
339,564,652
VTAK
0.91
+0.469
176,505,702
138.00
+1.07
165,371,572
LMDX
0.016
-0.018
120,553,903
SQQQ
7.13
-0.13
103,967,713
TVGN
1.72
+0.34
100,575,779
762.00
-84.71
85,558,284
LCID
2.63
-0.06
77,264,493
FXI
32.189
+1.34
71,359,123
NIO
5.22
+0.07
65,473,204
BRK-A
698,500.00
+860.00
1,273
NVR
9,924.40
+150.82
11,337
NFLX
763.89
+76.24
15,591,434
ISRG
521.15
+47.42
3,933,839
FCNCA
2,115.01
+29.74
62,457
DRUG
47.21
+25.51
26,292,996
AZO
3,182.07
+24.07
110,335
ASML
723.26
+22.66
4,509,733
MSTR
215.86
+22.44
22,212,108
ARGX
565.00
+21.16
368,107
MELI
1,629.32
-188.66
1,851,535
1,309.00
-138.99
2,237,917
MKL
1,395.13
-102.30
318,280
MPWR
838.63
-96.05
902,546
NOW
643.29
-87.83
5,025,012
MEDP
357.30
-79.88
1,004,401
MDB
236.06
-73.94
10,812,930
MCK
547.51
-70.00
4,067,959
FICO
1,973.46
-65.489
202,973
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....